Related Experiment Video

Updated: Jul 9, 2025

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.7K

PDE4 Phosphodiesterases in Cardiovascular Diseases: Key Pathophysiological Players and Potential Therapeutic Targets

Lídia Puertas-Umbert1,2, Judith Alonso1,2,3, Leif Hove-Madsen1,2,3

  • 1Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain.

International Journal of Molecular Sciences
|December 9, 2023
PubMed

Insights

Phosphodiesterase 4 (PDE4) enzymes regulate cyclic adenosine monophosphate (cAMP) signaling in cardiovascular cells. This review explores PDE4

Area of Science:

  • Cardiovascular Biology
  • Enzymology
  • Molecular Signaling

Background:

  • 3',5'-cyclic adenosine monophosphate (cAMP) acts as a crucial second messenger in cardiovascular physiology.
  • Phosphodiesterases (PDEs) control cAMP levels by hydrolyzing cyclic nucleotides, influencing cellular functions.
  • The PDE4 subfamily specifically modulates cAMP signaling with significant cardiovascular implications.

Purpose of the Study:

  • To review current knowledge on the role of PDE4 enzymes in cardiovascular function.
  • To highlight recent advances in understanding PDE4's contribution to cardiac and vascular health.
  • To discuss the therapeutic challenges of targeting PDE4 for cardiovascular diseases.

Main Methods:

  • Literature review of existing research on PDE4 and cardiovascular systems.
  • Synthesis of findings on PDE4's impact on vascular homeostasis and cardiac function.
  • Analysis of the complexities in developing PDE4 inhibitors for therapeutic use.

Main Results:

  • PDE4 enzymes are key regulators of vascular smooth muscle cell proliferation, migration, differentiation, and contraction.
  • PDE4 influences endothelial permeability, angiogenesis, and immune cell activation within the vasculature.
  • PDE4 plays a role in cardiac hypertrophy and arrhythmogenesis, impacting cardiomyocyte function.

Conclusions:

  • PDE4 enzymes are critical regulators of cardiovascular homeostasis and function.
  • Targeting PDE4 presents complex challenges for developing effective cardiovascular therapies.
  • Further research is needed to optimize PDE4-targeted strategies for cardiovascular disease management.
Keywords:
PDE4cardiovascular diseasestherapy

More Related Videos

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

13.4K
Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

9.4K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
161
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
532
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
188
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K